COMMUNIQUÉS West-GlobeNewswire

-
Shire plc : Rule 2.9 Announcement
26/06/2018 -
IBT plans to start its phase 3 study in the second half of 2018 and contracts CRO
26/06/2018 -
FIT Biotech Oy: EHVA clinical trial authorization granted for testing FIT-06 in UK
26/06/2018 -
Novartis Clear about Psoriasis survey data highlights challenges psoriasis patients face to achieve goal of clear skin
26/06/2018 -
Basilea starts clinical phase 2a expansion with BAL101553 in ovarian cancer and glioblastoma
26/06/2018 -
Fagron NV: Disclosure of received notifications
26/06/2018 -
Immuron Announces Board Appointment
26/06/2018 -
Zomedica Joins Russell 3000™ and Russell Microcap® Indexes
25/06/2018 -
Wave Life Sciences to Present at Parent Project Muscular Dystrophy Annual Conference
25/06/2018 -
UPDATE: Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
25/06/2018 -
Real-World Data Supports Association Between High Triglyceride Levels and Increased Cardiovascular Events and Healthcare Costs in People with Diabetes Mellitus
25/06/2018 -
AVROBIO, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option
25/06/2018 -
Eloxx Expands Leadership Team with Two Global Pharmaceutical Executives to Accelerate Growth
25/06/2018 -
Actinium Provides Update from Society of Nuclear Medicine and Molecular Imaging Annual Meeting
25/06/2018 -
Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
25/06/2018 -
Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
25/06/2018 -
Opiant Pharmaceuticals Announces Receipt of First Tranche from National Institutes of Health Grant for Development of OPNT003, Intranasal Nalmefene, for Treatment of Opioid Overdose
25/06/2018 -
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
25/06/2018 -
Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
25/06/2018
Pages